QSS
SAGE

Quantitative Systematic Strategies’s Sage Therapeutics SAGE Stock Holding History

Quantitative Systematic Strategies’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,128
Closed -$689K – 303
2021
Q2 		$689K Sell
12,128
-824
-6% -$58.2K 0.24% 153
2021
Q1 		$969K Sell
12,952
-7,688
-37% -$630K 0.15% 233
2020
Q4 		$1.79M Sell
20,640
-4,404
-18% -$325K 0.25% 124
2020
Q3 		$1.53M Buy
25,044
+1,989
+9% +$101K 0.27% 114
2020
Q2 		$959K Buy
23,055
+8,094
+54% +$294K 0.19% 177
2020
Q1 		$430K Sell
14,961
-4,906
-25% -$284K 0.35% 105
2019
Q4 		$1.43M Buy
19,867
+17,483
+733% +$2.15M 0.21% 146
2019
Q3 		$334K Sell
2,384
-644
-21% -$108K 0.08% 315
2019
Q2 		$554K Buy
+3,028
New +$517K 0.1% 233
2018
Q4 		– Sell
-2,486
Closed -$351K – 841
2018
Q3 		$351K Buy
+2,486
New +$384K 0.07% 380
2017
Q1 		– Sell
-4,457
Closed -$223K – 422
2016
Q4 		$223K Sell
4,457
-451
-9% -$21.3K 0.09% 267
2016
Q3 		$224K Buy
+4,908
New +$200K 0.08% 316
2016
Q2 		– Sell
-7,280
Closed -$228K – 505
2016
Q1 		$228K Buy
7,280
+2,083
+40% +$73.3K 0.09% 236
2015
Q4 		$304K Sell
5,197
-4,692
-47% -$232K 0.08% 545
2015
Q3 		$418K Buy
+9,889
New +$609K 0.21% 187

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Quantitative Systematic Strategies's SAGE Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Sage Therapeutics (SAGE) in Q3 2021, closing a stake of 12,128 shares — an estimated $689K sold.

Quantitative Systematic Strategies first reported a position in SAGE in Q3 2015 and held it in 15 quarters. The position peaked at $1.79M in Q4 2020. 225 funds tracked by Wall St. Rank hold SAGE as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Sage Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 12,128 Sage Therapeutics shares in Q3 2021, an estimated $689K.
  • Quantitative Systematic Strategies first reported a position in Sage Therapeutics in Q3 2015 and held it in 15 quarters.
  • Quantitative Systematic Strategies's Sage Therapeutics position peaked at $1.79M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.